Analytical performance and characterization of antibody immobilized magnetoelastic biosensors

2007 ◽  
Vol 2 (1) ◽  
pp. 27-33 ◽  
Author(s):  
Rajesh Guntupalli ◽  
R. S. Lakshmanan ◽  
J. Wan ◽  
D.-J. Kim ◽  
T. S. Huang ◽  
...  
2020 ◽  
Vol 35 (5) ◽  
Author(s):  
Fabio Marzaioli ◽  
Brunella Di Rienzo ◽  
Luisa Stellato ◽  
Egidio Di Fusco ◽  
Mauro Rubino ◽  
...  

2021 ◽  
Vol 126 ◽  
pp. 664-673
Author(s):  
Alexandre Mallet ◽  
Margaud Pérémé ◽  
Lorraine Awhangbo ◽  
Cyrille Charnier ◽  
Jean-Michel Roger ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (23) ◽  
pp. 7260
Author(s):  
Emmanouil Mavrogeorgis ◽  
Harald Mischak ◽  
Agnieszka Latosinska ◽  
Justyna Siwy ◽  
Vera Jankowski ◽  
...  

In recent years, capillary electrophoresis coupled to mass spectrometry (CE-MS) has been increasingly applied in clinical research especially in the context of chronic and age-associated diseases, such as chronic kidney disease, heart failure and cancer. Biomarkers identified using this technique are already used for diagnosis, prognosis and monitoring of these complex diseases, as well as patient stratification in clinical trials. CE-MS allows for a comprehensive assessment of small molecular weight proteins and peptides (<20 kDa) through the combination of the high resolution and reproducibility of CE and the distinct sensitivity of MS, in a high-throughput system. In this study we assessed CE-MS analytical performance with regards to its inter- and intra-day reproducibility, variability and efficiency in peptide detection, along with a characterization of the urinary peptidome content. To this end, CE-MS performance was evaluated based on 72 measurements of a standard urine sample (60 for inter- and 12 for intra-day assessment) analyzed during the second quarter of 2021. Analysis was performed per run, per peptide, as well as at the level of biomarker panels. The obtained datasets showed high correlation between the different runs, low variation of the ten highest average individual log2 signal intensities (coefficient of variation, CV < 10%) and very low variation of biomarker panels applied (CV close to 1%). The findings of the study support the analytical performance of CE-MS, underlining its value for clinical application.


2005 ◽  
Vol 111-112 ◽  
pp. 540-548 ◽  
Author(s):  
Edith Chow ◽  
Elicia L.S. Wong ◽  
Till Böcking ◽  
Quynh T. Nguyen ◽  
D. Brynn Hibbert ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document